[
  {
    "id": 221,
    "question": "A patient in the clinic he has continuous facial jerk and hand jerk (partials continua) how to treat:",
    "option_a": "iv valproic acid",
    "option_b": "iv diazepam",
    "option_c": "iv phenytoin",
    "option_d": "iv \u2026\u2026",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis question addresses a type of focal status epilepticus \u2013 continuous partial motor seizures (epilepsia partialis continua) \u2013 where abnormal electrical activity leads to repetitive jerking in specific muscle groups (e.g., face and hand). The immediate goal in management is to terminate the seizure activity, and benzodiazepines are the first\u2010line agents for status epilepticus.\n\n**Pathophysiology**\n\nIn status epilepticus, there is prolonged, unremitting neuronal firing. This occurs because inhibitory GABAergic mechanisms become impaired and excitatory activity becomes dominant. IV benzodiazepines (such as diazepam) enhance GABA-A receptor activity, helping to restore inhibitory tone and rapidly abort seizure activity. With continued seizures, receptor trafficking may render the seizures more refractory, which underpins the urgency of early intervention.\n\n**Clinical Correlation**\n\nA patient with continuous facial and hand jerks is manifesting focal seizure activity. This focal status\u2014despite being limited to specific regions\u2014can evolve and cause structural injury if not controlled promptly. Recognizing the pattern and rapidly instituting therapy is key to preventing worsening neuronal injury.\n\n**Diagnostic Approach**\n\nDiagnosis is primarily clinical though EEG confirmation is important if the diagnosis is in doubt. Differential diagnoses include epilepsia partialis continua secondary to structural lesions (e.g., stroke, tumor or infection) and non-epileptic movement disorders. Imaging (CT/MRI) helps evaluate for structural causes, while EEG confirms ongoing epileptiform activity.\n\n**Management Principles**\n\nThe latest guidelines (e.g., from the Neurocritical Care Society and ILAE) recommend immediate treatment of status epilepticus. First\u2010line management is IV benzodiazepines (diazepam, lorazepam) due to their rapid onset. If seizures persist, second\u2010line agents such as fosphenytoin, valproic acid, or levetiracetam are considered. In special populations such as pregnant or lactating women, the risks of fetal exposure to benzodiazepines (potential for fetal sedation, withdrawal) are weighed against the emergent need to control seizures, and therapy is individualized.\n\n**Option Analysis**\n\nOption A (IV valproic acid) is recognized as a second-line option once benzodiazepines have been tried. Option B (IV diazepam) fits the first-line recommendation for acute seizure termination. Option C (IV phenytoin) is also generally used as a second-line agent. Option D is incomplete. Therefore, Option B is the correct initial treatment.\n\n**Clinical Pearls**\n\n\u2022 In status epilepticus, prompt administration of benzodiazepines is critical, as delays increase morbidity and mortality.  \u2022 Recognize that focal status epilepticus may be due to an underlying lesion; work-up should include neuroimaging.\n\n**Current Evidence**\n\nRecent evidence continues to support benzodiazepines as the first-line treatment in all forms of status epilepticus, with multiple guidelines emphasizing rapid administration to improve outcomes. Research is also ongoing concerning the optimal sequencing and combination of second-line agents.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "id": 222,
    "question": "Patient with large left ICA territory infarction with image of CT shown (massive acute infarction), was found to have AFIB what is the appropriate treatment next to start:",
    "option_a": "Aspirin",
    "option_b": "DAPT",
    "option_c": "dabigatran",
    "option_d": "warfarin",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis question involves the acute management of a patient with a large left internal carotid territory infarction in the setting of atrial fibrillation (AF). AF is a common cause of cardioembolic stroke. However, in the setting of a massive infarct, the risk of hemorrhagic transformation must be carefully balanced against the benefits of anticoagulation.\n\n**Pathophysiology**\n\nIn patients with AF, emboli originating from the left atrium can lodge in the cerebral circulation (typically the ICA territory), leading to large infarctions. A massive infarct increases the risk of blood\u2013brain barrier disruption and hemorrhagic conversion, which can be exacerbated by early full-dose anticoagulation.\n\n**Clinical Correlation**\n\nThe CT showing a massive infarction indicates extensive brain tissue damage. Although AF typically mandates long-term anticoagulation for secondary stroke prevention, immediate initiation post-large infarct could precipitate hemorrhagic transformation. Thus, initial management with an antiplatelet agent is often preferred until the infarct stabilizes.\n\n**Diagnostic Approach**\n\nManagement begins with neuroimaging (CT/MRI) to assess infarct size and exclude hemorrhage, followed by cardiac evaluation (ECG, echocardiogram) for AF. Differential diagnoses include large artery atherosclerosis and lacunar strokes; however, the presence of AF shifts the etiology toward a cardioembolic source.\n\n**Management Principles**\n\nFor massive infarctions in patients with AF, current guidelines (AHA/ASA) recommend delaying full-dose anticoagulation by 1\u20132 weeks to reduce the risk of hemorrhagic transformation. In the acute phase, low-dose aspirin is used for antithrombotic therapy. When transitioning to long-term stroke prevention, direct oral anticoagulants (DOACs; e.g., dabigatran) or warfarin are considered, with DOACs often preferred in non-pregnant adults. For pregnant patients, warfarin is contraindicated, and low-molecular-weight heparin is often chosen, whereas lactating patients may use warfarin safely with monitoring.\n\n**Option Analysis**\n\nOption A (Aspirin) is correct as the immediate treatment to bridge the patient while delaying anticoagulation. Option B (Dual antiplatelet therapy) is generally not indicated for cardioembolic strokes. Options C (dabigatran) and D (warfarin) represent long-term anticoagulation strategies but are not initiated immediately in the context of a massive infarct due to the heightened hemorrhagic risk.\n\n**Clinical Pearls**\n\n\u2022 In cardioembolic strokes due to AF, full anticoagulation is essential for secondary prevention but must be timed appropriately after a large infarct.  \u2022 Massive infarcts require cautious initiation of any antithrombotic therapy to prevent hemorrhagic transformation.\n\n**Current Evidence**\n\nCurrent research and recent guideline updates recommend a delayed approach to anticoagulation in large infarcts, highlighting the safety benefit of initial antiplatelet therapy (aspirin) before transitioning to full anticoagulation. Ongoing studies continue to refine the optimum timing balance between reducing recurrence and avoiding hemorrhage.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "id": 223,
    "question": "SCA artery infarction scenario what you will find also:",
    "option_a": "Rt. ptosis Ipsilateral",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis question pertains to identifying additional clinical findings associated with a Superior Cerebellar Artery (SCA) infarction. SCA strokes typically affect structures of the cerebellum, leading to deficits in coordination and balance.\n\n**Pathophysiology**\n\nThe superior cerebellar artery supplies the superior aspect of the cerebellum, including regions responsible for coordinating limb movements and maintaining balance. Infarction in this territory can cause degeneration or dysfunction of the cerebellar cortex and deep nuclei, leading to ipsilateral cerebellar deficits.\n\n**Clinical Correlation**\n\nPatients with SCA infarction may present with ipsilateral limb dysmetria, ataxia, dysdiadochokinesia (impaired ability to perform rapid alternating movements), and sometimes vertigo or nausea. These symptoms help differentiate the infarct from involvement of other cerebellar territories.\n\n**Diagnostic Approach**\n\nDiagnosis is made via neuroimaging (MRI is more sensitive than CT for posterior fossa strokes) and clinical examination. Differentiation from infarctions in other cerebellar arterial territories, like the Anterior Inferior Cerebellar Artery (AICA) or Posterior Inferior Cerebellar Artery (PICA), rests on subtle differences in the clinical presentation \u2013 for example, AICA infarcts may also involve facial nerve findings, while PICA infarcts are associated with lateral medullary (Wallenberg) syndrome.\n\n**Management Principles**\n\nManagement of an SCA stroke follows guidelines for acute ischemic stroke, including potential thrombolysis if within the therapeutic window, supportive care, and monitoring for complications such as cerebellar edema that could cause brainstem compression. In pregnant women, thrombolysis can be used if indicated after careful risk\u2013benefit analysis, and similar principles apply during lactation with attention to medication safety profiles.\n\n**Option Analysis**\n\nAlthough the option texts are incomplete in this question, Option A mentions \u201cRt. ptosis Ipsilateral\u201d which is more suggestive of an oculomotor or midbrain involvement rather than a cerebellar syndrome. Option B is the marked answer and, based on classical SCA infarct presentations, likely represents clinical signs such as ipsilateral cerebellar ataxia and dysmetria. Without the full list, we assume Option B correctly identifies the typical cerebellar findings seen in SCA infarction.\n\n**Clinical Pearls**\n\n\u2022 SCA infarctions classically produce ipsilateral cerebellar deficits rather than cranial nerve III findings (such as ptosis).  \u2022 A careful clinical examination paired with posterior fossa imaging is crucial in localizing cerebellar strokes.\n\n**Current Evidence**\n\nThe latest imaging techniques (especially diffusion-weighted MRI) have improved the detection of cerebellar infarcts. Recent stroke guidelines also emphasize a tailored approach to managing posterior circulation strokes, including vigilant monitoring for complications like brainstem compression in cerebellar infarctions.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "id": 224,
    "question": "30 y/o male found unconscious at street What you expect as the mechanism of injury for attached CT (looked like coup countercoup bleed \"repeated question from previous exam\")",
    "option_a": "Aneurysmal",
    "option_b": "Trauma",
    "option_c": "HTN",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis question highlights a scenario with a 30\u2010year\u2010old male found unconscious and a CT scan showing a lesion that resembles a coup\u2013countercoup injury. Coup\u2013countercoup injuries are a type of traumatic brain injury (TBI) resulting from blunt force trauma.\n\n**Pathophysiology**\n\nIn coup\u2013countercoup injuries, the brain is injured at the site of impact (coup) and on the opposite side (countercoup) due to the brain's movement within the skull. The rapid deceleration forces generate contusions and bruising, which can lead to intracranial hemorrhage and edema.\n\n**Clinical Correlation**\n\nThe patient\u2019s presentation (unconsciousness) combined with CT findings consistent with a coup\u2013countercoup injury points to a trauma-related mechanism. This distinguishes it from aneurysmal bleeds (which usually present with subarachnoid hemorrhage) or hypertensive hemorrhages (which typically affect deep brain structures in older individuals).\n\n**Diagnostic Approach**\n\nDiagnosis is established with neuroimaging (CT scan being the first-line modality in acute trauma). Differential diagnoses include aneurysmal subarachnoid hemorrhage and hypertensive intracerebral hemorrhage; however, the imaging pattern and patient profile (young age, history of trauma) point toward a traumatic cause.\n\n**Management Principles**\n\nManagement of traumatic brain injury includes stabilization of airway, breathing, and circulation (the ABCs), followed by neuroimaging and neurosurgical evaluation. Intracranial pressure monitoring and supportive care are key components. For pregnant patients, while imaging with CT is generally avoided when possible due to radiation concerns, if necessary, appropriate shielding is used. The same management principles apply with heightened caution.\n\n**Option Analysis**\n\nOption A (Aneurysmal) is incorrect as aneurysmal bleeds produce a different pattern (typically subarachnoid hemorrhage) and are less common in a young trauma patient. Option B (Trauma) is the correct answer, accurately reflecting the coup\u2013countercoup injury mechanism. Option C (Hypertension) is unlikely in a 30-year-old with traumatic findings and would more typically produce deep hemorrhages in older patients.\n\n**Clinical Pearls**\n\n\u2022 Coup\u2013countercoup injuries result from inertial forces that damage both the site of impact and the opposite side; always consider trauma in young patients with such CT findings.  \u2022 Rapid identification and management of TBI are critical to prevent secondary brain injury.\n\n**Current Evidence**\n\nRecent guidelines on traumatic brain injury emphasize early recognition, stabilization, and neuroimaging. Advances in CT technology have improved the early detection of coup\u2013countercoup lesions, and current management protocols stress the importance of monitoring intracranial pressure and using neuroprotective strategies where appropriate.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "id": 225,
    "question": "A female who develops transverse sinus thrombosis what is the most accurate statement to describe this patient",
    "option_a": "female sex is a major risk",
    "option_b": "seizure is the most common presenting symptoms",
    "option_c": "transverse sinus is the most commonly affected sinus in CVT",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nCerebral venous thrombosis (CVT) is a condition characterized by clot formation in the dural venous sinuses. It disproportionately affects women, largely due to risk factors such as oral contraceptive use, pregnancy, and the postpartum period.\n\n**Pathophysiology**\n\nIn CVT, thrombosis occurs in one or more of the dural venous sinuses resulting in impaired venous drainage, increased intracranial pressure, and possibly venous infarctions or hemorrhages. Hypercoagulable states, frequently encountered in females (e.g., due to estrogen exposure), play a central role.\n\n**Clinical Correlation**\n\nPatients often present with headache (the most common symptom), focal neurological deficits, seizures, and signs of raised intracranial pressure. Although seizures may occur, they are not the predominant presenting feature. The strong female preponderance is a critical clue in the clinical scenario.\n\n**Diagnostic Approach**\n\nDiagnosis is made with neuroimaging studies such as magnetic resonance imaging (MRI) combined with magnetic resonance venography (MRV). Differentials include migraines, meningitis, intracerebral hemorrhage, and subarachnoid hemorrhage, but the clinical context along with imaging aids in differentiation.\n\n**Management Principles**\n\nFirst-line management involves anticoagulation with low molecular weight heparin (LMWH) even in cases with hemorrhagic transformation. In pregnancy and lactation, LMWH is preferred due to its safety profile. Subsequent management includes transitioning to oral anticoagulants with appropriate monitoring and risk factor modification.\n\n**Option Analysis**\n\nOption A (female sex is a major risk) is correct, as women are indeed at higher risk due to hormonal factors and related hypercoagulable states. Option B is incorrect because, although seizures can occur, headache remains the most common presenting symptom. Option C, while noting that the transverse sinus is a common site, is less accurate as literature variably points to both the superior sagittal and transverse sinuses; moreover, the emphasis on female risk makes option A more specific in this context.\n\n**Clinical Pearls**\n\n1. Always assess for prothrombotic risk factors in women with CVT. 2. Headache is the most common presenting symptom in CVT. 3. Early anticoagulation is key to reducing morbidity.\n\n**Current Evidence**\n\nRecent guidelines and research from the American Heart Association (AHA) endorse prompt anticoagulation in CVT. Studies continue to clarify which sinus is most commonly involved, yet the strong female predisposition remains universally acknowledged.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "id": 226,
    "question": "Site of lesion in weber syndrome",
    "option_a": "Base of midbrain",
    "option_b": "tegmentum",
    "option_c": "tectum",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nWeber syndrome is a classical brainstem stroke syndrome characterized by ipsilateral oculomotor nerve dysfunction (manifesting as ptosis and ophthalmoplegia) and contralateral motor deficits. It results from a lesion in the midbrain.\n\n**Pathophysiology**\n\nThe syndrome is typically due to infarction or hemorrhage at the ventral (basal) portion of the midbrain affecting the exiting fibers of the oculomotor nerve and the corticospinal tracts that travel through the cerebral peduncles. The lesion is usually vascular in origin, commonly involving branches of the posterior cerebral artery.\n\n**Clinical Correlation**\n\nPatients present with an ipsilateral third cranial nerve palsy (leading to diplopia and ptosis) along with contralateral hemiparesis, which reflects the involvement of adjacent motor pathways.\n\n**Diagnostic Approach**\n\nNeuroimaging (MRI with diffusion-weighted imaging) is key in confirming the lesion in the ventral midbrain. Differential diagnoses include other midbrain syndromes such as Benedikt\u2019s syndrome, which additionally includes tremor and ataxia due to red nucleus involvement.\n\n**Management Principles**\n\nAcute management follows standard stroke protocols including thrombolysis (if within window and no contraindications), blood pressure control, and supportive care. For patients who are pregnant or lactating, thrombolytic therapy and supportive measures are considered on a case-by-case basis following current AHA/ASA guidelines, with multidisciplinary consultation.\n\n**Option Analysis**\n\nOption A (Base of midbrain) is correct because Weber syndrome classically involves the ventral midbrain (basis pedunculi), not the tegmentum (dorsal aspect) or the tectum (posterior aspect).\n\n**Clinical Pearls**\n\n1. Weber syndrome is marked by the combination of oculomotor dysfunction and contralateral motor weakness. 2. Lesions are localized to the ventral midbrain. 3. Vascular supply from the posterior cerebral artery is typically implicated.\n\n**Current Evidence**\n\nRecent imaging studies and guidelines continue to support the ventral midbrain localization in Weber syndrome. Management strategies align with broader ischemic stroke management protocols adapted to brainstem strokes.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "id": 227,
    "question": "A man who has right side weakness and dysphasia, on stroke work up he was found to have left MCA severe stenosis what is the most appropriate management:",
    "option_a": "endarterectomy",
    "option_b": "stenting",
    "option_c": "Aspirin and plavix",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nA patient with right-sided weakness and dysphasia with left MCA stenosis is suffering an ischemic stroke related to intracranial atherosclerotic disease. The appropriate management of such a condition involves medical therapy rather than invasive procedures.\n\n**Pathophysiology**\n\nAtherosclerotic disease of the left middle cerebral artery leads to luminal narrowing, reduced cerebral perfusion, and ultimately ischemia in the dependent brain territories. The resulting stroke produces contralateral motor and language deficits due to involvement of the dominant hemisphere.\n\n**Clinical Correlation**\n\nThe presentation of right-sided weakness and dysphasia reflects the involvement of the left MCA territory, which is responsible for motor control of the contralateral side of the body and language functions (in the dominant hemisphere).\n\n**Diagnostic Approach**\n\nDiagnosis involves neuroimaging with CT/MRI to confirm infarct and vessel imaging (CTA/MRA) to assess the degree of stenosis. Differential considerations include embolic stroke from cardiac sources and lacunar strokes. Carotid duplex is more relevant for extracranial disease.\n\n**Management Principles**\n\nFirst-line management is aggressive medical therapy with dual antiplatelet therapy (typically aspirin and clopidogrel) for a duration based on recent trials (e.g., 21-90 days, often 90 days in high-risk individuals). Second-line interventions, such as stenting or endarterectomy, are largely reserved for extracranial stenosis (e.g., carotid endarterectomy) and are not first-line for intracranial lesions. In pregnant or lactating patients with stroke, low-dose aspirin is generally considered safe, with careful multidisciplinary management tailoring the risk\u2013benefit ratio.\n\n**Option Analysis**\n\nOption A (endarterectomy) is typically used for extracranial carotid stenosis and is not indicated for intracranial MCA stenosis. Option B (stenting) has been explored in clinical trials (e.g., SAMMPRIS) but has shown higher periprocedural risks compared to aggressive medical management. Option C (Aspirin and Plavix) is correct, representing the current standard of care for symptomatic intracranial atherosclerotic disease.\n\n**Clinical Pearls**\n\n1. Intracranial atherosclerotic strokes are best managed medically with dual antiplatelet therapy. 2. Differentiation between intracranial and extracranial pathology is crucial when considering revascularization strategies. 3. SAMMPRIS trial data influenced the move toward medical management in these cases.\n\n**Current Evidence**\n\nRecent trials, notably the SAMMPRIS study, have reinforced that aggressive medical management (including dual antiplatelet therapy and risk factor modification) provides superior outcomes compared to stenting for intracranial stenosis.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "id": 228,
    "question": "A patient who presented with inability to read his own hand writing, his comprehension for spoken language, fluency and repetition is normal (nothing was mentioned on his ability to write) what is the most common artery :",
    "option_a": "PCA",
    "option_b": "PICA",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThe clinical presentation described is that of pure alexia (alexia without agraphia), a syndrome in which patients lose the ability to read despite preserved writing abilities and intact spoken language comprehension.\n\n**Pathophysiology**\n\nThis syndrome is most commonly encountered with infarcts in the territory of the left posterior cerebral artery (PCA), particularly affecting the left occipital lobe and often involving the splenium of the corpus callosum. The lesion disrupts visual processing and the transfer of visual information to language areas.\n\n**Clinical Correlation**\n\nPatients with this syndrome can write and speak fluently, but when they attempt to read, whether it is their own writing or printed words, they are unable to decode the visual stimuli into meaningful language. This dissociation between reading and writing highlights the localization of the lesion.\n\n**Diagnostic Approach**\n\nNeuroimaging (MRI) is essential for localizing the infarct, which typically involves the left occipital lobe. Differential diagnoses include other language disorders such as aphasia; however, in pure alexia, the preservation of spoken language distinguishes it from more global aphasic syndromes.\n\n**Management Principles**\n\nAcute management follows standard ischemic stroke protocols, including consideration for thrombolytic therapy if within the appropriate time window. Long-term management involves antiplatelet therapy, risk factor modification, and rehabilitation (including occupational and speech therapy). In pregnant or lactating patients, aspirin is typically acceptable with multidisciplinary review to balance risks and benefits, while thrombolytic therapy is used only under strict guidelines.\n\n**Option Analysis**\n\nOption A (PCA) is correct because the syndrome of pure alexia is most commonly associated with infarcts in the left PCA territory. Option B (PICA) is incorrect as it typically supplies parts of the cerebellum and lateral brainstem rather than the occipital lobe.\n\n**Clinical Pearls**\n\n1. Pure alexia (alexia without agraphia) is a disconnection syndrome resulting from left occipital infarct and splenial involvement. 2. The preservation of writing despite impaired reading is a key diagnostic feature. 3. The left PCA is the most often implicated vessel in this syndrome.\n\n**Current Evidence**\n\nRecent research emphasizes the role of detailed neuroimaging in localizing lesions in stroke syndromes. Current stroke management guidelines continue to support prompt intervention in PCA strokes, with tailored approaches for special populations including pregnant and lactating patients.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "id": 229,
    "question": "Image of DWI showing watershed infarction in one side what to do :",
    "option_a": "CTA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nWatershed infarctions occur at the border zones between major cerebral arteries. In cases where DWI imaging shows a unilateral watershed pattern, it raises concern for hemodynamic compromise, most commonly due to an upstream arterial stenosis (often in the internal carotid artery). The next logical step is to evaluate the vascular anatomy, which is best done with vascular imaging such as a CTA.\n\n**Pathophysiology**\n\nWatershed zones are vulnerable to hypoperfusion. When there is significant stenosis or occlusion (commonly in the carotid circulation), these areas receive less than adequate blood flow, resulting in infarcts. CTA helps identify the site and severity of arterial narrowing, guiding further management.\n\n**Clinical Correlation**\n\nPatients with watershed strokes can present with variable neurological deficits depending on the exact regions affected. The imaging pattern on DWI is distinct, and identifying the cause (such as carotid stenosis) is essential as it may alter future management, including possible revascularization procedures.\n\n**Diagnostic Approach**\n\nOnce DWI suggests a watershed infarct, vascular imaging (CTA in this case) is indicated. Differential diagnoses include embolic strokes and small vessel disease strokes; however, their imaging and clinical histories usually differ. CTA helps differentiate a hemodynamic mechanism from an embolic one by showing vascular narrowing or occlusion.\n\n**Management Principles**\n\nAfter identifying a watershed infarct with CTA, management includes optimizing blood pressure, antiplatelet therapy, and addressing the underlying cause such as carotid atherosclerosis. For patients who are pregnant or lactating, CTA can be performed with proper shielding, and risk factor management (blood pressure, lipids) should follow guidelines that take maternal and fetal safety into account.\n\n**Option Analysis**\n\nOption A (CTA) is correct because it provides crucial information on the vascular status (e.g., carotid/vertebral arteries) that likely contributed to the watershed infarct. The other options were either not provided or not appropriate for the next step in this scenario.\n\n**Clinical Pearls**\n\n1) Unilateral watershed infarctions on DWI should prompt an evaluation for significant ipsilateral carotid stenosis. 2) Vascular imaging is a key next step in differentiating hemodynamic strokes from embolic phenomena.\n\n**Current Evidence**\n\nRecent AHA/ASA guidelines emphasize early vessel imaging in acute ischemic stroke patients. Emerging research also supports the prompt use of CTA to lay the groundwork for possible interventions such as carotid revascularization if significant stenosis is identified.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "id": 230,
    "question": "Clear scenario of old man presented within the window of tpa about what to give:",
    "option_a": "Tpa",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIntravenous thrombolytic therapy (tPA) is the standard treatment for acute ischemic stroke if the patient is within the appropriate therapeutic window and meets eligibility criteria. The scenario describes an elderly man who is within this window.\n\n**Pathophysiology**\n\ntPA works by catalyzing the conversion of plasminogen to plasmin, the enzyme responsible for breaking down fibrin clots. In the context of an ischemic stroke, the timely dissolution of the clot can restore blood flow, salvaging penumbral brain tissue.\n\n**Clinical Correlation**\n\nPatients presenting with acute stroke symptoms require rapid evaluation including a non-contrast CT to exclude hemorrhage. If within 3-4.5 hours (and meeting other criteria) tPA is recommended. The older man in the scenario is an appropriate candidate assuming no contraindications are found on further workup.\n\n**Diagnostic Approach**\n\nInitial assessment requires neuroimaging (usually a CT scan) to rule out hemorrhage. After confirming an ischemic event, the patient\u2019s history, time of symptom onset, and contraindications are reviewed. Differential diagnoses include stroke mimics like seizures or migraine, but the acute focal neurological deficits help distinguish true stroke.\n\n**Management Principles**\n\nThe first-line management for eligible patients with acute ischemic stroke is IV tPA, ideally given within 3 to 4.5 hours of symptom onset. Subsequent treatments may include endovascular therapies if a large vessel occlusion is found. In pregnant or lactating women, tPA has been used with caution in select cases after weighing maternal and fetal risks, and consultation with specialists is advised.\n\n**Option Analysis**\n\nOption A (tPA) is correct because the patient fits the criteria for thrombolysis. The other possible options (though not provided) would likely include alternatives not appropriate in the acute phase or less evidence-based interventions.\n\n**Clinical Pearls**\n\n1) Time is brain \u2013 rapid recognition and treatment of acute ischemic stroke significantly improves outcomes. 2) Exclusion of hemorrhage via CT is essential before administering tPA.\n\n**Current Evidence**\n\nThe latest guidelines continue to support IV tPA in eligible acute ischemic stroke patients. Recent studies have also explored extended time windows and advanced imaging techniques, but standard practice remains to initiate tPA as early as possible within the defined window.",
    "exam_year": "2020",
    "exam_type": "Part II"
  }
]